Cann American Cancels $30K Convertible Debt To Increase Shareholder Value

Cann American Corp. CNNA canceled $30,000 worth of convertible notes.

During the uncertainty surrounding the Covid pandemic, the company took on loans to ensure it could maintain its operational and investment activities as a precautionary measure. Recent revenue projections based on Cann American's stake in the Cannagram delivery service, the launch of its C-Juice line of products and additional deals to be announced in upcoming releases have caused the company to re-evaluate the loans and begin the process of cancellation and restructuring.

The debt was purchased privately by Cann American CEO, Jason Black, and subsequently canceled in the interest of maintaining and increasing shareholder value. All cancellations will be reflected in future quarterly and annual filings.

In addition to eliminating convertible notes, Cann American is also in talks to cancel several million shares outstanding, which the company believes will close very soon.

Finally, the company is evaluating additional options to reward shareholders such as a forward split or stock buy-back program.

"The company is always interested in feedback from our shareholders. Just as we withdrew our Reg-A based on shareholder sentiment, we have considered the convertible debt and we're acting accordingly to eliminate those concerns," Black said.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.